Evolution of dobutamine echocardiography protocols and indications: Safety and side effects in 3,011 studies over 5 years

Journal of the American College of Cardiology

Volumn 29, Issue 6, 1997, Pages 1234-1240

  Secknus, Maria Anna ^a   Marwick, Thomas H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; AGED; ARTICLE; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

NON-PROGRAMMATIC;

ADRENERGIC BETA-AGONISTS; AGED; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SAFETY;

EID: 0030958384     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00039-9     Document Type: Article

References (26)

1. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 83:1991;1605-1614.
2. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol. 67:1991;1311-1318.
3. Eichelberger JP, Schwarz KQ, Black ER, Green RM, Ouriel K. Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. Am J Cardiol. 72:1993;602-607.
4. Poldermans D, Fioretti PM, Forster T, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation. 87:1993;1506-1512.
5. Davila-Roman VG, Waggoner AD, Sicard GA, Geltman EM, Schechtman KB. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol. 21:1993;957-963.
6. Poldermans D, Arnese M, Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol. 26:1995;648-653.
7. Poldermans D, Fioretti PM, Boersma E, et al. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med. 97:1994;119-125.
8. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 27:1996;132-139.
9. Takeuchi M, Araki M, Nakashima Y, Kuroiwa A. The detection of residual ischemia and stenosis in patients with acute myocardial infarction with dobutamine stress echocardiography. J Am Soc Echocardiogr. 7:1994;242-252.
10. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 88:1993;405-415.
11. Watada H, Ito H, Oh H, et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol. 24:1994;624-630.
12. Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrario M. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol. 72:1993;124G-130G.
13. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy comparison with positron emission tomography . J Am Coll Cardiol. 15:1990;1021-1031.
14. McNeill AJ, Fioretti PM, el-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 70:1992;41-46.
15. Fioretti PM, Poldermans D, Salustri A, et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J. 15:1994;355-360.
16. Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography experience in 1118 patients . Circulation. 88:1993;15-19.
17. Baudhuin T, Marwick T, Melin J, Wijns W, D'Hondt AM, Detry JM. Diagnosis of coronary artery disease in elderly patients safety and efficacy of dobutamine echocardiography . Eur Heart J. 14:1993;799-803.
18. Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography a prospective, multicentre study (Echo Dobutamine International Cooperative Study Group) . Lancet. 344:1994;1190-1192.
19. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms . J Am Soc Echocardiogr. 2:1989;358-367.
20. Bach DS, Muller DW, Gros BJ, Armstrong WF. False positive dobutamine stress echocardiograms characterization of clinical, echocardiographic and angiographic findings . J Am Coll Cardiol. 24:1994;928-933.
21. Baptista J, Arnese M, Roelandt JR, et al. Quantitative coronary angiography in the estimation of the functional significance of coronary stenosis correlations with dobutamine-atropine stress test . J Am Coll Cardiol. 23:1994;1434-1439.
22. Poldermans D, Fioretti PM, Boersma E, et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol. 73:1994;456-459.
23. Cohen A, Chauvel C, Benhalima B, Blanchard B. Complication of dobutamine stress echocardiography. Lancet. 345:1996;201-202.
24. Scherer D, Kaltenbach M. Frequency of life-threatening complications associated with stress testing. Dtsch Med Wochenschr. 104:1979;1161-1164.
25. Tanimoto M, Pai RG, Jintapakorn W, Shah PM. Mechanisms of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol. 76:1995;26-30.
26. Lieberman EB, Heinle SK, Wildermann N, Waugh RA, Kisslo JA, Bashore TM. Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment? Am Heart J. 129:1995;1121-1126.